- Fee assured
- Verified this account
- Accredited Cataract Full Pathway provider
I offer the Full Pathway cataract surgery package for Bupa customers ...more
I offer Bupa customers standard cataract surgery on the Full Pathway package option at Nuffield Health Newcastle upon Tyne Hospital .
This package includes your appointments before and after surgery, as well as your surgery and mono-focal lenses. It means you won’t use up your out-patient benefit or receive any additional bills from your surgeon (or anaesthetist, if you need one) for eligible treatment.
Please call the Bupa Eye Care team to find out more about and to pre-authorise your treatment on 0345 600 7267.
I am a senior Consultant Ophthalmologist with specialist expertise in cataract surgery and medical retina conditions such as macular degeneration and diabetic retinopathy. I perform around 600 cataracts a year. I lead the medical retina service at the Royal Victoria Infirmary in Newcastle upon Tyne. I am a Nationally recognised expert in this field being a member of the Royal College of Ophthalmologist's Council and Scientific Committee and a member of the Oxford Congress Council. I have attended Advisory boards for Bayer, Novartis, Allergan and Alimera Science.
At the Royal Victoria Infirmary I and my team operate on about 16 cataracts a week. At the Nuffield Health Hospital I use standard, toric and multifocal intraocular lenses if required. As the thought of cataract surgery can be stressful I also have an anaesthetist with me who can offer some calming medicine if desired.
My Private consultations are usually at the Nuffield where I have use of an OCT to accurately image the retina in addition to the full range of ophthalmic equipment expected. I also provide expert advice on lid conditions, glaucoma and a range of ophthalmic conditions.
Additional imaging can be organised at the Royal Victoria Infirmary if needed.
I am actively involved in clinical trials of potential new treatments and ways of managing conditions, currently on diabetic maculopathy, central serous retinopathy and macular degeneration.
Areas of interest
Cataract surgery ; Cataract surgery including toric and multifocal lens implants ; Medical retina including macular degeneration and diabetic retinopathy ; Intravitreal injections ; Eye - external disorders ; Glaucoma
- Amy Thompson
- AmyChryst Medical Secretarial Services 39 Pennine Drive ASHINGTON NE63 0TE
- 07875 552387
Current NHS consultant posts held
Newcastle Upon Tyne Hospitals NHS foundation Trust
Royal Victoria Infirmary
Newcastle Upon Tyne NE1 4LP
Treatments of macular degeneration, diabetic retinopathy and retinal vein occlusions. Currently involved in 7 clinical studies.
Presentations made in 2017
Scottish Ophthalmological Club 15th September:
Euroretina 10th September : Barcelona
Oxford Congress 3-5 July
Royal College of Ophthalmologists Annual Congress 22-24 May
ARVO; Baltimore 8-10 May
APAO Singapore 2-4th March
Painting, travel, birdwatching.
6 Clinical excellent awards
Richardson Cross medal (South Western Ophthalmological Society) 2016
The Role of New Imaging Methods in Managing Age-Related Macular Degeneration.
Talks SJ; Aftab AM; Ashfaq I; Soomro T.
Asia-Pacific Journal of Ophthalmology. , 2017 Sep 14
Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration.
Talks JS; et al. UK Aflibercept Users Group.
Eye. , 2017 Jun 23.
Second-year visual acuity outcomes of nAMD patients treated with aflibercept: data analysis from the UK Aflibercept Users Group.
Almuhtaseb H; Johnston RL; Talks JS; Lotery AJ.
Eye. , 2017 Jun 16
Purtscher-like retinopathy associated with squamous cell carcinoma of the cervix.
Ting DS; Smith J; Talks SJ.
International Ophthalmology. , 2017 Feb 06
Real-world experience with 0.2mug/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.
Bailey C; Chakravarthy U; Lotery A; Menon G; Talks J; Medisoft Audit Group.
Eye. , 2017 Jul 24
First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration.
Talks JS; et al; United Kingdom Aflibercept Users Group.
Ophthalmology. 123(2):337-43, 2016 Feb
The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group.
Talks SJ; Gupta R; Buckley S.
Eye. 30(8):1146, 2016 08
New vessels detected on wide-field imaging compared to two-field and seven-field imaging: implications for diabetic retinopathy screening image analysis.
Talks SJ; et al.
British Journal of Ophthalmology. 99(12):1606-9, 2015 Dec
Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel.
McKibbin M; Devonport H; Gale R; Gavin M; Lotery A; Mahmood S; Patel PJ; Ross A; Sivaprasad S; Talks J; Walters G.
Eye. 29 Suppl 1:S1-S11, 2015 Jul
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. [Review]
Freund KB; Korobelnik JF; Devenyi R; Framme C; Galic J; Herbert E; Hoerauf H; Lanzetta P; Michels S; Mitchell P; Mones J; Regillo C; Tadayoni R; Talks J; Wolf S.
Retina. 35(8):1489-506, 2015 Aug.
Wide-field imaging and OCT vs clinical evaluation of patients referred from diabetic retinopathy screening.
Manjunath V; Papastavrou V; Steel DH; Menon G; Taylor R; Peto T; Talks J.
Eye. 29(3):416-23, 2015 Mar.
I have had no readmissions, infections or mortality from cataract surgery in the last 10 years.
- MRCP Royal College of Physicians 1992
- FRCOphth Royal College of Ophthalmologists 1994
- MB B chir Cambridge 1988
Professional bodies (positions held - last 3 yrs)
- Council member of Royal College of Ophthalmologists Royal College of Ophthalmologists 2012
- Council member of Oxford Congress Oxford Congress 2006
- Member of Royal College of Ophthalmologists scientific committee Royal College of Ophthalmologists 2012
Details of entry to specialist register
- Ophthalmologist, 1999
Affiliations / memberships
American Academy of Ophthalmologists
Royal College of Ophthalmologists
- Nuffield Health Newcastle upon Tyne Hospital,...
- 09:00 - 12:00
- 0191 281 6131
- Nuffield Health Newcastle upon Tyne Hospital,...
- 17:30 - 19:30
- 0191 281 6131
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
0191 281 6131